Ehrlich's ascites fluid adsorbed over Protein A containing Staphylococcus aureus Cowan I produces inhibition of tumor growth

Immunopharmacology and Immunotoxicology

Volumn 21, Issue 1, 1999, Pages 89-108

  Verma, A S ^a,e   Dwivedi, P D ^a,b   Mishra, Anil ^a,c   Ray, P K ^a,d  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b TULANE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^d BOSE INSTITUTE   (India)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; GLUTATHIONE TRANSFERASE; STAPHYLOCOCCUS PROTEIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCITES FLUID; CELL VIABILITY; CONTROLLED STUDY; EHRLICH ASCITES TUMOR CELL; MALE; MOUSE; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; TUMOR IMMUNOLOGY;

ANIMALIA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 0032964283     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.3109/08923979909016396     Document Type: Article

References (41)

1. Catalona W.J., Ratcliff T.L., and McCool R.E. Interferon-γ induced by S. aureus Protein A augments natural killing and ADCC. Nature 291:77, 198.1
2. Ray P.K., Cooper D.R., Bessett J.G. and Mark R. Antitumor effect of Staphylococcus aureus organism. Fed. Proc. 38: 4558, 1979.
3. Ray PK, McLaughlin D., Mohammed J., Idiculla A., Rhoads J.E.Jr., Mark R., Basset J.G. and Cooper D.R. Ex vivo immunoadsorption of IgG or its complexes - A new modality of cancer treatment. In:. Immune Complexes and Plasma Exchanges in Cancer Patients, edited by Serrou B., Rosenfeld C., p. 197, Elsvier/North Holland Biomedical Press, 1981.
4. Ray P.K., Raychaudhuri S., and Allen P., Mechanism of regression of mammary adenocarcinoma in rats following plasma adsorption over protein A containing Staphylococcus aureus. Cancer Res. 42: 4970, 1982.
5. Ray P.K. Immunosupressor control as a modality of cancer treatment: Effect of plasma adsorption with Staphylococcus aureus Protein A. In: Contemporary Topics in Immunobiology, edited by Salinas F.A., Hanna M.G.Jr. p. 147 Plenum Press Corporation N. Y, 1985.
6. Hjelm H., Hjelm K., and Sjoquist J. Protein A from Staphylococcus aureus : Its isolation by affinity chromatography and its use as immunosorbent for the isolation of immunoglobulins. FEBS Letters 28:73, 1972.
7. Langone J.J. Use of staphylococcal protein A as an immunological reagent. J. Immunol. Methods. 20: 241, 1978.
8. Dima S., and Moraru I. The in vivo effect of protein A on tumor growth. Neoplasma 33:679, 1986.
9. Messerschmidt G.L., Henry D.H., Snyder H.W.Jr., Bertram J , Mittleman A., Ainsworth S., Fire J., Viola M.J., Louie J., and Am binder E. et al. Protein A immunotherapy in the treatment of cancer: An Update. Semin. Hematol. 26:19, 1989.
10. Terman D.S. Protein A and staphylococcal products in neoplastic diseases. Crit. Rev. Oncol. Hematol. 4:103, 1985.
11. Kiprov D.D., Lippet R., Miller R.G., Sandstrom E., Jones F.R., Cohen R.J., Abrams D. and Busch D.F. The use of plasmapheresis, lympocytopheresis and Staphylococcal protein A immunoadsorption as immunomodulatory therapy in patients with AIDS and AIDS related conditions. J. Clin. Apheresis. 3:133, 1986.
12. Gaddis T.G., Guthrie T.H.Jr., Drew M.J., Sahud M., Howe R.B., and Mittelman A Treatment of plasma refractory thrombotic thrombocytopenic purpura with protein A immunoabsorption. Am. J. Hematol 55:55, 1997.
13. Mittleman A., Bertram J., Henry D.H., Snyder H.W.Jr., Messerschmidt G.L., Ciavarella D., Ainsworth S., Kiprov D., and Arlin Z. Treatment of patients with HIV thrombocytopenic and hemolytic uremia syndrome with Protein A (Prosorba Column) in immunoadsorption. Semin. Hematol 26: 15, 1989.
14. Snyder H.W.Jr., Mittelman A., Oral A., Messerschmidt G.L., Henry D.H., Korec S., Bertram J.H., Guthrie T.H.Jr., Ciavarella D., Wuest D., et. al. Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura/hemolytic uremia syndrome by protein A immunoadsorption of plasma. Cancer 71: 1882, 1993.
15. Ray P.K. and Bandyopadhyay S.K. Inhibition of rat mammary tumor growth by purified protein A- A potential antitumor agent. Immunol. Commun. 12: 453, 1983.
16. Das C., and Langone J.J. Correlation between antitumor activity of Protein A and in vivo formation of defined high molecular weight complexes with immunoglobulin G in Balb/c mice. Cancer Res. 47:2002, 1987.
17. Ray P.K., Bandyopadhyay S.K., Dohadwala M., Canchanapan P., and Mobini J. Antitumor activity of non-toxic doses of Protein A. Cancer Immunol. Immunother. 18: 29, 1984.
18. Ray P.K., Besa E., Idiculla A., Rhoads J.E.Jr, Bassett J.G., and Cooper D.R. Extracorporeal immunoadsorption of myeloma IgG and autoimmune antibodies : A clinically feasible modality of treatment. Clin. Exp. Immunol. 42:308, 1980.
19. Ray P.K., Mohammed J., Allen P., Raychaudhuri S., Dohadwala M., Bandyopadhyay S., and Mark R. Effect of frequency of plasma adsorption over protein A containing Staphylococcm aureus on regression of rat mammary adenocarcinoma : Modification of antitumor immune response and tumor histopathology. J. Biol. Respon. Modif. 8:39, 1984.
20. Bandyopadhyay S.K., and Ray P.K. Introduction of bacterial components in post adsorbed plasma during adsorption with Staphylococcus aureus. Cancer 56:266, 1985.
21. Ray P.K., Idiculla A., Mark R., Rhoads J.E.Jr., Thomas H., Basset J.G., and Cooper D.R. Extracorporeal immunoadsorption of plasma from metastatic colon carcinoma patient by Protein A-containing nonviable Staphylococcus aureus. Clinical, biochemical, serological and histological evaluation of patient's response. Cancer 49: 1800, 1982.
22. Hook G.E., Bend J.R., Hoel D., Fouts J.R., and Gram T.E. Preparation of lung microsomes and comparison of the distribution of enzymes between the subcellular fraction of rabbit lung and liver J. Pharmacol. Exp. Ther. 182: 474, 1972.
23. Mazel P. In: Fundamentals of drug metabolism and drug disposition, edited by LaDu B.N., Mamdel H.G. and Way E.L. p. 527 , Williams and Wilkins Co. Baltimore, 1971.
24. Habig W.H., Pabst M.J., and Jacoby W.B. Glutathione-S-transferase the first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249: 7140, 1974.
25. Jollow D.J., Mitchell J.R., Zampaglione N., and Gillette J.R. Bromobenzene induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic intermediate. Pharmacology 11:151, 1974.
26. Lowry O.H., Rosebrough N.J., Fair A.L. and Randall R.J. Protein measurement with folin phenol reagent. J. Biol. Chem. 193: 265, 1951.
27. Senedecor G.W. and Cochorn W.G.(1967) In: Stastical Methods p. 1000. The Iowa State College Press, Ames.
28. Baliant J.Jr., Ikeda Y., Langone J.J., Shearer W.T., Daskal I., Meek K., Cook G., Henry J., and Terman D.S. Tumoricidal response following perfusion over immobilized protein A : Identification of immunoglobulin oligomers in serum after perfusion and their partial characterization. Cancer Res. 44:734, 1984.
29. Lopez-Mortalla N., Lopez-Zabalza M.J., Subira M.L., Borras-Cuesta F., Perez-Mediavilla L.A., and Santiago E. Immunomodulation induced by synthetic peptides derived from Staphylococcus aureus protein A. Biochim. Biophys. Acta. 1221:153, 1994.
30. Kronvall G., Quie P.G., and Williams R.C.Jr. Quantitation of staphylococcal protein A: Determination of equilibrium constant and number of Protein A residues on bacteria. J. Immunol. 104: 273, 1970.
31. Langone J.J., Das C., Bennett D., and Terman D.S. Generation of C3a, C4a and C5a anaphylatoxins after contact with protein A of Staphylococcus aureus and immobilized protein A reagent used in serotherapy of cancer. J. Immunol. 133:1057,1984.
32. Kassel R.L., Old L.J., Carswell E.A., Fiore N.C. and Hardy W.D.Jr., Serum mediated leukemia cell destruction in AKR mice. J. Exp. Med. 138 : 925, 1973.
33. Goodman M.G., Chenoweth D.E., and Weigle W.O. Induction of interleukin 1 secretion and enhancement of humoral immunity by binding of human C5a to macrophage surface C5a receptors. J. Exp. Med. 156:912, 1982.
34. Romagnani S., Amadori A., Giudizi M.G., Biagiotti R., Maggi E., and Ricci M., Different mitogenic activities of soluble and insoluble staphylococcal protein A(SPA). Immunology 35: 471, 1978.
35. Sami S., Takano S., Majima T., Aso H., Nakamura T. and Ishida N. Low molecular weight immunosuppressive factors found in elevated amounts in cancer ascites fluid of mice 1. Isolation, identification and immunosuppressive effect of uric acid and uracil. J. Immunopharmacol. 8: 39,1986.
36. Takano S., Sami S., Majima T., and Ishida N. Low molecular weight immunosuppressive factors found in elevated amount in cancer ascites fluid of mice 2: 1-methyladenosine isolated from cancer ascites fluid enhance Listeria infection in mice. J. Immunopharmacol. 8: 59, 1986.
37. Tamura K., Shibata Y., Matsuda Y., and Ishida N. Isolation and characterization of an immunosuppressive acidic protein (IAP) from ascites fluid of cancer patients. Cancer Res. 41: 3244, 1981
38. Yamazaki H., Nitta K., and Umezawa H. Immunosupression induced with cell free fluid of Ehrlich's carcinoma ascites and its fraction GANN 64: 831973.
39. Baluna R., and Vitetta E.S. Vascular Leak Syndrome: a side effect of immunotherapy. Immunopharmacology 37: 117, 1997.
40. Wazeswka-Czyzewska M., Wesierska-Gadek J., and Leguthko L. Immunostimulatory effect of Zinc in patients with acute lymphobastoid leukemia. Folia Hematol. (Leipzig) 105 : 727, 1978.
41. Chengalis, C.P., Dodd D.C., Means J.R., and Kostonis F.N. Protection by Zinc against Acetaminophen induced hepatotoxicity in mice. Fund. Appl. Toxicol. 6: 278, 1986.